Navigation Links
NeoVista Presents Anatomic Outcomes of Novel Wet AMD Therapy at 2008 American Society of Retina Specialists Meeting
Date:10/13/2008

hich have previously been presented from this trial. This hypothesis will be tested in the ongoing multicenter Phase III registration trial."

Dr. Brown's analysis examined over 1400 images from patients enrolled in the company's ongoing Phase II pilot study, which includes 34 trial participants (with a mean age of 72 years) treated from June 2006 to April 2007 at two centers in Brazil and one in Mexico. These patients, with predominantly classic, minimally classic, or occult (with no classic) choroidal neovascularization (CNV), received a single 24 Gy treatment of NeoVista's epiretinal brachytherapy in combination with two intravitreal injections of an anti-VEGF agent (bevacizumab), which are delivered to maximize the acute therapeutic response. Preliminary data show that NeoVista's targeted radiation therapy is well tolerated and may provide a new approach to restore the patient's vision and improve their quality of life.

"Dr. Brown's analysis is providing valuable information on our novel technology," said John N. Hendrick, President and CEO of NeoVista. "For someone with his credibility and expertise in the field of retinal medicine to independently analyze and present this data is quite encouraging and provides further proof of concept of our technique. We know that the mechanism of action of radiation is different from any therapy currently available for wet AMD and we look forward to the potential promise of significantly decreasing the burden of wet AMD therapy."

The observational analysis was presented at ASRS while NeoVista continues to enroll patients in the company's pivotal Phase III trial, CABERNET (CNV Secondary to AMD Treated with BEta RadiatioN Epiretinal Therapy). CABERNET is a multicenter, randomized, controlled study that will enroll 450 subjects at 45 sites worldwide, evaluating the safety and efficacy of NeoVista's epiretinal brachytherapy delivered concomitantly with the FDA-approved anti-VEGF therapy Lucentis(R) (ranibizum
'/>"/>

SOURCE NeoVista, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer
2. The Lewin Group Presents McCain and Obama Health Policies: Cost and Coverage Compared Analysis
3. Stater Bros. Markets Presents $1,143,000 Check to Muscular Dystrophy Association
4. Curemark CEO Presents Autism Findings at Prestigious Neurobiology Conference at Oxford
5. AMA Foundation Presents the Arthur N. Wilson, MD Scholarship to Promising Medical Student From Southeast Alaska
6. USA-ONE Interactive Presents a Free Webinar Series Introducing Docuvation – An Online Document Management Solution
7. AMA Foundation Presents $10,000 Scholarships to Promising Medical Students
8. Neurotherapeutics presents special issue on new treatments for Alzheimers disease
9. Vertos Medical Inc. Presents Clinical Data of its MILD™ Procedure at the 5th Annual Innovative Techniques in Spine Surgery Conference in Los Cabos, Mexico
10. Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary
11. ExonHit Presents Therapeutic and Diagnostic Programs for Alzheimers at ICAD 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Alan Mozes HealthDay ... -- Cancer patients burdened by stress and family conflicts ... following their operation, a new study suggests. Investigators ... to have a nearly three times greater risk for ... quality of life. "We,ve long known that patient ...
(Date:9/19/2014)... a leading anti-ageing clinic has called its HGH Therapy ... has grown tremendously across USA in the last decade with ... It has far reaching benefits for ageing men and women ... and active lifestyle even beyond their middle age. , ... MetroMD said, “HGH or Human Growth hormones are the building ...
(Date:9/19/2014)... September 19, 2014 In partnership with Raw ... an active part of the project’s social media efforts. StudioPMG ... aims to re-define the perception of beauty as it applies ... as an idea by Shelly Baer and Vanessa Silberman, who ... as sexy and beautiful. Ginny Dixon, Wendy Crawford, Susan Solman ...
(Date:9/19/2014)... Recent two-generation approaches to reducing poverty that help ... from researchers, advocates, and foundations. By combining education ... move to jobs that offer a path out ... for children, these programs aim to improve the ... a new report from the National Center for ...
(Date:9/19/2014)... NY (PRWEB) September 20, 2014 As summer ... Krishnan DMD in Queens, NY now reminds area patients about ... than 80% of our population affected by gum disease, there ... longer.” , For over 20 years Dr. Krishnan has treated ... Hills office location. “Most patients that come in due to ...
Breaking Medicine News(10 mins):Health News:Family Squabbles Can Derail Recovery From Cancer Surgery 2Health News:Family Squabbles Can Derail Recovery From Cancer Surgery 3Health News:MetroMD Announces Better HGH Therapy - the ‘God Particle’ of Human Health 2Health News:OC Healthcare Agency StudioPMG Partners with The Raw Beauty Project ™ NYC 2014 2Health News:A two generation lens: Current state policies fail to support families with young children 2Health News:New York Periodontist Dr. Prabha Krishnan Now Raises Awareness about the Dangers of Untreated Decay, Gingivitis and Gum Disease During Self-Awareness Month 2Health News:New York Periodontist Dr. Prabha Krishnan Now Raises Awareness about the Dangers of Untreated Decay, Gingivitis and Gum Disease During Self-Awareness Month 3
... , , , GLENVIEW, Ill., ... palliative medicine has launched a new Web site -- www.PalliativeDoctors.org ... and how it can help patients with serious illnesses, and their ... and Palliative Medicine (AAHPM) created www.PalliativeDoctors.org to meet a ...
... , , NORRISTOWN, Pa., Aug. 24 ... drugs for clinical research and clinical trials, has expanded ... new capability provides their clients with an efficient solution ... in clinical trials. Distribution Management Services is an ...
... , , , HACKENSACK, ... of The Prostate Net announced the organization,s latest major initiative ... symposium targeting patients, caregivers and medical professionals will take place ... Center for University Life in New York City. Joined ...
... , WASHINGTON, Aug. 24 Secretary of Veterans Affairs ... taking steps to assist Veterans seeking compensation for Post-Traumatic Stress Disorder ... are being addressed vigorously and comprehensively by this administration as we ... Secretary Shinseki. , , The VA is publishing ...
... , , ATLANTA, Aug. 24 ... by the American Diabetes Association (ADA), kicks off in Atlanta on ... F earless A frican-Americans C onnected and E ... also supported by Aetna, educates and empowers African-Americans living with diabetes ...
... EMERYVILLE, Calif., Aug. 24 Nov ... ), a clinical stage company developing non-antibiotic anti-infective compounds for the ... fungal infections, announced today the company has received acceptance to deliver ... Diseases Society of America October 29 - November 1, 2009 in ...
Cached Medicine News:Health News:www.PalliativeDoctors.org: Organization Sheds Light on Hospice and Palliative Care 2Health News:Prostate Net Announces: Major Medical Education Initiative for Patients, Caregivers and Healthcare Professionals 2Health News:Prostate Net Announces: Major Medical Education Initiative for Patients, Caregivers and Healthcare Professionals 3Health News:Secretary Shinseki Moves to Simplify PTSD Compensation Rules 2Health News:Grammy(R)-Nominated R&B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African-Americans to be Victorious in the Face of Diabetes 2Health News:Grammy(R)-Nominated R&B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African-Americans to be Victorious in the Face of Diabetes 3Health News:Grammy(R)-Nominated R&B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African-Americans to be Victorious in the Face of Diabetes 4Health News:NovaBay Pharmaceuticals to Present New Pre-Clinical Data on Lead Anti-Infective Compound for use in Onychomycosis at the 2009 IDSA Annual Meeting 2Health News:NovaBay Pharmaceuticals to Present New Pre-Clinical Data on Lead Anti-Infective Compound for use in Onychomycosis at the 2009 IDSA Annual Meeting 3
(Date:9/19/2014)... SOUTH EASTON, Mass. , Sept. 19, 2014 ... the "Company") today announced it has received and ... throughput Barozyme HT48 instruments and has begun to ... believes the first instrument will be ready for ... will be built and released at a rate ...
(Date:9/19/2014)... , September 19, 2014 ... IQ den äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der jetzt ... interaktive PDF, verfügbar unter pharmaserialisation.com , zeigt ... sie jeweils in Kraft treten. Für ... nicht länger um das "ob", sondern darum, "wann" ...
(Date:9/19/2014)... and CAMBRIDGE, Mass. ... Inc. (PGDx), a provider of advanced cancer ... Medicines , a leader in discovering and developing ... today disclosed the first-ever comprehensive genomic study of ... deadly cancer of the female reproductive system, also ...
Breaking Medicine Technology:Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4
... Choice and Access Now (PCAN) – a coalition ... nation and Texas, committed to preserving quality and ... for the passage of Senate Bill 7, which ... for Texans and their community pharmacies.  Among these ...
... Lilly and Company (NYSE: LLY ) announced ... the Clinical Endocrinology website, showed that Axiron® (testosterone) topical ... primary study objective to restore testosterone levels to the ... low testosterone. In addition, secondary outcomes showed that the ...
Cached Medicine Technology:Pharmacy Choice and Access Now Coalition Applauds Passage of Senate Bill 7 During Texas Legislature's Special Session 2Newly Published Study Showed Axiron® (testosterone) Topical Solution Restored Testosterone Levels to Normal Range in Hypogonadal Men 2Newly Published Study Showed Axiron® (testosterone) Topical Solution Restored Testosterone Levels to Normal Range in Hypogonadal Men 3Newly Published Study Showed Axiron® (testosterone) Topical Solution Restored Testosterone Levels to Normal Range in Hypogonadal Men 4Newly Published Study Showed Axiron® (testosterone) Topical Solution Restored Testosterone Levels to Normal Range in Hypogonadal Men 5Newly Published Study Showed Axiron® (testosterone) Topical Solution Restored Testosterone Levels to Normal Range in Hypogonadal Men 6
... new AquaGuide Ureteral Access Sheath, you can ... access sheath - plus an entirely new ... sheath is designed with a proprietary dual ... second working channel for a variety of ...
Used during the performance of balloon dilation procedures to inflate and deflate the balloon and measure the pressure within the balloon during the procedure. Supplied sterile in peel-open packages....
... Straight Channel; 33 or 42 cm Working ... Ureteroscopes offer a small distal diameter with ... the ureter for diagnosis and treatment. The ... for large operating instruments, mechanical (Lithoclast) or ...
Semi-Rigid Ureteroscope...
Medicine Products: